Pei H. Luo

No.3218 Qiuhua Road, Wutong Sub District
Tongxiang, 314500, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

How should we interpret the use of vonoprazan and proton pump inhibitors during immunotherapy for hepatocellular carcinoma?

How should we interpret the use of vonoprazan and proton pump inhibitors during immunotherapy for hepatocellular carcinoma?

Journal: International journal of clinical oncology

Published: December 22, 2025

Effect of methotrexate on cutaneous mucosal inflammation and infection in patients with hematological tumors.

Effect of methotrexate on cutaneous mucosal inflammation and infection in patients with hematological tumors.

Journal: Asian journal of surgery

Published: April 01, 2024

Rapid quantification of bioactive compounds in Salvia miltiorrhiza Bunge derived decoction pieces, dripping pill, injection, and tablets by polarity-switching UPLC-MS/MS.

Rapid quantification of bioactive compounds in Salvia miltiorrhiza Bunge derived decoction pieces, dripping pill, injection, and tablets by polarity-switching UPLC-MS/MS.

Journal: Frontiers in chemistry

Published: June 08, 2022

Exosomal microRNA-15a from mesenchymal stem cells impedes hepatocellular carcinoma progression via downregulation of SALL4.

Exosomal microRNA-15a from mesenchymal stem cells impedes hepatocellular carcinoma progression via downregulation of SALL4.

Journal: Cell death discovery

Published: September 17, 2020

Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with p53 Deficiency.

Inhibition of USP14 Deubiquitinating Activity as a Potential Therapy for Tumors with p53 Deficiency.

Journal: Molecular therapy oncolytics

Published: June 13, 2019

MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma.

MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma.

Journal: Oncology letters

Published: December 11, 2016

Reduced miR-105-1 levels are associated with poor survival of patients with non-small cell lung cancer.

Reduced miR-105-1 levels are associated with poor survival of patients with non-small cell lung cancer.

Journal: Oncology letters

Published: May 19, 2016

Incidence and physiological mechanism of carboplatin-induced electrolyte abnormality among patients with non-small cell lung cancer.

Incidence and physiological mechanism of carboplatin-induced electrolyte abnormality among patients with non-small cell lung cancer.

Journal: Oncotarget

Published: May 01, 2016

Reduced miR-125a levels associated with poor survival of patients with hepatocellular cancer.

Reduced miR-125a levels associated with poor survival of patients with hepatocellular cancer.

Journal: Oncology letters

Published: April 13, 2016

Preclinical studies of targeted therapies for CD20-positive B lymphoid malignancies by Ofatumumab conjugated with auristatin.

Preclinical studies of targeted therapies for CD20-positive B lymphoid malignancies by Ofatumumab conjugated with auristatin.

Journal: Investigational new drugs

Published: June 05, 2013

Showing 1-10 of 10

Last Updated: 09/26/2026